Recap: Integra Lifesciences Q4 Earnings


Integra Lifesciences IART reported its Q4 earnings results on Wednesday, February 28, 2024 at 06:00 AM.

Here's what investors need to know about the announcement.


Integra Lifesciences missed estimated earnings by -1.0%, reporting an EPS of $0.89 versus an estimate of $0.9.

Revenue was down $983 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 1.0% increase in the share price the next day.

Here's a look at Integra Lifesciences's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.78 0.57 0.74 0.90
EPS Actual 0.76 0.71 0.74 0.94
Revenue Estimate 387.12M 374.07M 373.21M 397.95M
Revenue Actual 382.42M 381.30M 380.85M 398.02M

To track all earnings releases for Integra Lifesciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!